GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells
Abstract The single nucleotide polymorphism (SNP) rs9679162 located on GALNT14 gene predicts therapeutic outcomes in patients with intermediate and advanced hepatocellular carcinoma (HCC), but the molecular mechanism remains unclear. Here, the associations between SNP genotypes, GALNT14 expression,...
Main Authors: | Yu-De Chu, Tan-Chi Fan, Ming-Wei Lai, Chau-Ting Yeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-11-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-022-05419-y |
Similar Items
-
Stromal-epithelial interaction induces GALNT14 in prostate carcinoma cells
by: Elena D. Czyrnik, et al.
Published: (2023-08-01) -
The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer
by: Qing Hu, et al.
Published: (2022-09-01) -
O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer
by: Lixia Zhou, et al.
Published: (2022-08-01) -
B4GALNT3 regulates glycosylation of sclerostin and bone massResearch in context
by: Sofia Movérare-Skrtic, et al.
Published: (2023-05-01) -
B4galnt2-mediated host glycosylation influences the susceptibility to Citrobacter rodentium infection
by: Abdulhadi Suwandi, et al.
Published: (2022-08-01)